Fred Hutchinson Cancer Center
Avatar

Management of MPNs for the Community Oncologist

By Fred Hutchinson Cancer Center FEATURING H. Joachim Deeg
By Fred Hutchinson Cancer Center FEATURING H. Joachim Deeg
642 views
May 11, 2023
4 Comments
Login to view comments. Click here to Login

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Related Content

AUTOPLAY
27:37
Indy Hematology Review

Review of Myeloproliferative Neoplasms

Feat. A. Tefferi
18:04
Ruben Mesa

Momelotinib for Myelofibrosis: Top 10 Things You Should Know Post-FD…

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay
21:52
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "MF, ET, and PV - Highlights and Clinical Imp…

Feat. D. Tremblay
31:43
Indy Hematology Review

Myelofibrosis: Chronic and Blast Phase - 2023 Algorithms for Risk St…

Feat. A. Tefferi
10:02
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "The Best of MPNs - Highlights & Key Take…

Feat. R. Mesa
09:27
ASH 2022 Conference Coverage

MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…

Feat. M. McMullin
16:25
Northwestern Medicine Oncology and Hematology

Diagnosis and Goals of Therapy in PV

Feat. B. Stein
12:07
Douglas Tremblay

Monitoring Patients With MF: When to Switch Treatment

11:39
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

2024 Updates in Myeloproliferative Neoplasms

Feat. E. Hexner
17:51
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Chronic GVHD: A Case-Based Discussion

Feat. L. Perry
51:20
Jerry Spivak

Polycythemia Vera: Disease Overview, Treatment Landscape, and Curren…

15:31
Icahn School of Medicine at Mount Sinai

Myelofibrosis Treatment Options Beyond the JAK/STAT Pathway

Feat. M. Kremyanskaya
53:01
PleXus Communications

Changing Pharmacological Paradigms for Higher-Risk Myelofibrosis

Feat. R. Rampal
11:09
Jeanne Palmer

Management of Clinical Manifestations in Myelofibrosis

15:41
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: Addressing Anemia in Myelofibrosis

Feat. S. Oh
17:34
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: Novel Non-JAK Inhibitor Therapies for Myelofibrosis

Feat. J. Mascarenhas
07:22
Integrity Continuing Education

Targeted Treatment of Myelofibrosis: Novel Pathways & Mechanisms…

Feat. R. Mesa, A. Gerds
24:48
Indy Hematology Review

2024 Updates on Myelofibrosis and Systemic Mastocytosis

Feat. R. Rampal
04:06
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "PERSIST-2 Landmark OS Analysis - Spleen V…

Feat. H. Ajufo